Is Colgate's Productivity Program a Catalyst for Its Margins? — Positive
CL Zacks Investment Research — December 29, 2025CL's productivity program is easing cost pressures and paving the way for mid-25% margins, balancing efficiency with brand investment.
Is KMB's Brand Investment Strategy Enhancing Its Competitive Edge? — Positive
KMB Zacks Investment Research — December 29, 2025Kimberly-Clark's disciplined brand reinvestment is driving sustained volume-plus-mix growth, share gains, and margin expansion despite cost pressures.
Bronstein, Gewirtz & Grossman LLC Urges Bitdeer Technologies Group Investors to Act: Class Action Filed Alleging Investor Harm — Neutral
BTDR GlobeNewsWire — December 29, 2025New class action for Bitdeer Technologies (BTDR) investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 2/2/2026
If I Could Retire With Only 3 Dividend Growth Investments — Neutral
AMLP BAM EPD KMI MLPA OKE SCHD TRP VIG WMB XLK Seeking Alpha — December 29, 2025The real goal of dividends in retirement isn't what most investors think. I discuss 3 investments that combine nicely to form a powerful dividend growth machine for retirement. I also discuss the biggest risk with each of these investments.
These biotech stocks are getting hammered by shocking brittle-bone treatment study results — Negative
MREO RARE Market Watch — December 29, 2025Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.
January Effect 2026: 4 Beaten-Down Stocks Poised for a Strong Rebound — Positive
GLBE GTLB IOT NCNO Zacks Investment Research — December 29, 2025January Effect 2026 spotlights GitLab, nCino, Samsara, and Global-e Online as beaten-down stocks eye AI-driven rebounds after a volatile 2025.
NVR (NVR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About BiomX (PHGE) Rating Upgrade to Buy — Positive
PHGE Zacks Investment Research — December 29, 2025BiomX (PHGE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Farmers National (FMNB) Upgraded to Buy: What Does It Mean for the Stock? — Positive
FMNB Zacks Investment Research — December 29, 2025Farmers National (FMNB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About Immuneering (IMRX) Rating Upgrade to Buy — Positive
IMRX Zacks Investment Research — December 29, 2025Immuneering (IMRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why — Positive
ADCT Zacks Investment Research — December 29, 2025ADC Therapeutics (ADCT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Beyond Meat (BYND) Upgraded to Buy: Here's What You Should Know — Positive
BYND Zacks Investment Research — December 29, 2025Beyond Meat (BYND) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Royal Bank (RY) Upgraded to Buy: Here's What You Should Know — Positive
RY Zacks Investment Research — December 29, 2025Royal Bank (RY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Planet Fitness (PLNT) Upgraded to Buy: Here's What You Should Know — Positive
PLNT Zacks Investment Research — December 29, 2025Planet Fitness (PLNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Magna (MGA) Upgraded to Buy: Here's What You Should Know — Positive
MGA Zacks Investment Research — December 29, 2025Magna (MGA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
@ProsperTradingAcademy's Scott Bauer is a big fan of the pullback seen in gold and offers an example trade in the SPDR Gold Shares ETF (GLD). Turning to stock movers, Scott sees significant trading opportunities in Oklo Inc.'s (OKLO) pullback and in Boeing's (BA) bounce back.
We believe that Accenture (ACN) stock may represent a solid value buy in today's market. After years of premium valuation driven by robust digital-transformation demand, ACN shares have pulled back as enterprise IT spending softened and growth moderated.
2026 Market Outlook: S&P 500 Looks Expensive, But Biotech Could Outperform Under The Hood — Neutral
IVV SPLG SPXL SPY SSO UPRO VOO Seeking Alpha — December 29, 20252025 market gains were strong but heavily concentrated in megacap tech, setting up a potential 2026 rotation toward broader participation. I expect a neutral-to-slightly positive 2026 for SPY, with upside primarily driven by earnings, not multiple expansion.
Why SMX's Platform Is Serving Continuity Instead of Trust in Global Supply Chains — Neutral
SMX Accesswire — December 29, 2025NEW YORK, NY / ACCESS Newswire / December 29, 2025 / For decades, supply chains ran on assumed trust. Documents moved with goods.
Tesla (NASDAQ:TSLA) is undoubtedly one of the most divisive stocks in the market.
